CNL Healthcare Properties II Inc. is a Maryland corporation that incorporated on July 10, 2015. We elected to be taxed as a real estate investment trust (“REIT”) for United States (“U.S.”) federal income tax purposes beginning with the year ended December 31, 2017 and our intention is to be organized and operate in a manner that allows us to remain qualified as a REIT for federal income tax purposes. We are sponsored by CNL Financial Group, LLC (“Sponsor” or “CNL”). The terms “us,” “we,” “our,” “Company” and “CNL Healthcare Properties II” include CNL Healthcare Properties II Inc. and each of its subsidiaries. On March 2, 2016, pursuant to a registration statement on Form S-11 under the Securities Act of 1933, we commenced our initial public offering of up to $1.75 billion (“Primary Offering”), in any combination, of Class A, Class T and Class I shares of common stock on a “best efforts” basis, which meant that CNL Securities Corp. (“Dealer Manager”), an affiliate of our Sponsor, used its best efforts but was not required to sell any specific amount of shares. We also offered up to $250 million, in any combination, of Class A, Class T and Class I shares pursuant to our distribution reinvestment plan (“Reinvestment Plan” and, together with the Primary Offering, the “Offering”). On August 31, 2018, our board of directors approved the termination of our Offering and the suspension of the Reinvestment Plan, effective October 1, 2018. We also suspended our share redemption plan (“Redemption Plan”) and discontinued our stock dividends concurrently. In October 2018, we deregistered the unsold shares of common stock under our previous registration statement on Form S-11.
Company profile
Ticker
CHPII
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12G
Securities registration termination
27 Mar 20
8-K
Entry into a Material Definitive Agreement
23 Mar 20
8-K
Completion of Acquisition or Disposition of Assets
4 Mar 20
8-K
Entry into a Material Definitive Agreement
28 Jan 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
8-K
Departure of Directors or Certain Officers
7 Nov 19
SC TO-T/A
Third party tender offer statement (amended)
30 Oct 19
SEC STAFF
SEC staff action: Order
25 Sep 19
SC 14D9
Tender offer solicitation
17 Sep 19
8-K
Submission of Matters to a Vote of Security Holders
11 Sep 19
Latest ownership filings
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
4
Stephen H Mauldin
24 Sep 19
4
John F. Starr
24 Sep 19
SC 13G
Beneficial ownership report
15 Nov 18
4
Stephen H Mauldin
22 Oct 18
4
John F. Starr
22 Oct 18
4
JAMES M SENEFF JR
20 Mar 18
3
John F. Starr
14 Feb 18
3
JAMES M SENEFF JR
14 Feb 18
5
JAMES M SENEFF JR
14 Feb 18